Abivax (ABVX) Share-based Compensation (2024 - 2026)

Abivax's Share-based Compensation history runs 3 years deep, the most recent figure standing at $26.5 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 436.68% year-over-year to $26.5 million; the TTM figure through Mar 2026 stood at $62.1 million (up 201.76% YoY), while the FY2025 annual figure was $41.2 million, up 90.66% from the prior year.
• Share-based Compensation was $26.5 million for Q1 2026 at Abivax, up from $15.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $26.5 million in Q1 2026 to a low of $4.8 million in Q4 2024.
• Historically, Share-based Compensation has averaged $9.9 million across 3 years, with a median of $6.3 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation slipped 21.11% in 2025, then soared 436.68% in 2026.
• A 3-year view of Share-based Compensation shows it stood at $4.8 million in 2024, then surged by 215.28% to $15.0 million in 2025, then soared by 76.28% to $26.5 million in 2026.
• The last three Share-based Compensation figures came in at $26.5 million (Q1 2026), $15.0 million (Q4 2025), and $13.4 million (Q3 2025), per Business Quant data.